Abstract

Gestational diabetes mellitus (GDM) is a detrimental condition for human pregnancy associated with endothelial dysfunction and endothelial inflammation in the fetoplacental vasculature and leads to increased cardio-metabolic risk in the offspring. In the fetoplacental vasculature, GDM is associated with altered adenosine metabolism. Adenosine is an important vasoactive molecule and is an intermediary and final product of transmethylation reactions in the cell. Adenosine kinase is the major regulator of adenosine levels. Disruption of this enzyme is associated with alterations in methylation-dependent gene expression regulation mechanisms, which are associated with the fetal programming phenomenon. Here we propose that cellular and molecular alterations associated with GDM can dysregulate adenosine kinase leading to fetal programming in the fetoplacental vasculature. This can contribute to the cardio-metabolic long-term consequences observed in offspring after exposure to GDM.
Original languageEnglish
Number of pages11
JournalBiochimica et biophysica acta-Molecular basis of disease
Volume1866
Issue number2
DOIs
Publication statusPublished - 1 Feb 2020
Externally publishedYes

Keywords

  • gestional diabetes
  • adenosine kinase
  • fetal programming
  • placenta
  • endothelium
  • epigenetic regulation
  • dna methylation
  • nitric-oxide
  • s-adenosylhomocysteïne
  • umbilical-cord
  • nucleosidetransport
  • vein endothelial-cells
  • insulin-resistance

Research Focus Areas Hanze University of Applied Sciences * (mandatory by Hanze)

  • No Hanze research focus area applicable

Research Focus Areas Research Centre or Centre of Expertise * (mandatory by Hanze)

  • No Research Focus Areas Research Centre or Centre of Expertise applicable

Publinova themes

  • Health

Fingerprint

Dive into the research topics of 'Adenosine kinase and cardiovascular fetal programming in gestational diabetes mellitus'. Together they form a unique fingerprint.

Cite this